Atomoxetine in Melanocortin Obesity Syndrome | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Atomoxetine in Melanocortin Obesity Syndrome	Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition	Recruiting	Phase 2	2026-08-07		NCT06899178

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Icahn School of Medicine at Mount Sinai	256
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617
Vanderbilt University Medical Center	299

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Mount Sinai Hospital	New York	United States	225
Nationwide Children's Hospital	Columbus	United States	309
Vanderbilt University Medical Center	Nashville	United States	427